News

Welcome to the Cytrellis News Center. Here you can explore the latest news and information about the company, upcoming events and recent publications.

As seen in NewBeauty

“Top Aesthetic Trends to Expect in 2020, According to Dermatologists and Plastic Surgeons”

New York dermatologist Doris Day, MD calls the fractional facelift the “most exciting and revolutionary of all of the new rejuvenation technology….ever!” According to Dr. Day, the treatment relies on micro-coring of skin—a technique where “anywhere from dozens to hundreds of tiny, full thickness cores of the skin are removed”—which leaves bridges of normal skin between them, “allowing for skin contraction and a veritable lift, without surgery and with very little downtime.”

VISIT SITE TO LEARN MORE

As seen in Dermatology News

“Novel dermal micro-coring device holds promise for moderate to severe wrinkles”

September 7, 2019.  “An investigative dermal micro-coring device designed for improvement of moderate to severe facial wrinkles and tightening is poised to become a game-changer in the minimally invasive aesthetics field…”

VISIT SITE TO LEARN MORE

“Despite the immeasurable rise of machines and injectables over the last 20 years, one could argue that a weak spot still exists in the non-surgical armamentarium: a truly powerful way to lift and tighten the skin…”

As seen in Marie Claire

“The Next 25 Years in Beauty”

“In 2 years, you won’t need surgery to give your face a lift”… Cytrellis treatment “is like a facelift by a thousand small cuts instead of a few big ones, but there’s no scarring and the results are subtler,” says Dr. Mathew Avram, faculty director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital. “Trials are underway now.”

VISIT SITE TO LEARN MORE

Cytrellis Completes $28.5 Million Series B Financing

Woburn, MA

Cytrellis announced today that it has received $28.5 million in a Series B round which included existing investors ARCH Venture Partners, the Merz Venture Initiative and new investors, Partner Fund Management and BioMatics Captial.

Learn more